Skip to main content
logo
Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.370
+0.030 (1.28%)
At close: Nov 6, 2026, 4:00 PM EST
2.360
-0.010 (-0.42%)
After-hours: Nov 6, 2026, 7:49 PM EST

Sana Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
45.3744.364.0473.367.0650.41
Research & Development
96.61146.66207.43253.6204.37274.66
Operating Expenses
141.98190.96271.47326.9271.43325.07
Operating Income
-141.98-190.96-271.47-326.9-271.43-325.07
Interest & Investment Income
4.583.8510.479.943.760.68
Other Non Operating Income (Expenses)
5.184.61-0.01-0.05-0.670.31
EBT Excluding Unusual Items
-132.22-182.51-261.01-317.01-268.34-324.09
Asset Writedown
-2.3-46.91-6.39-7.01-4.5-
Other Unusual Items
-14.75-14.750.6440.773.36-31.84
Pretax Income
-149.27-244.17-266.76-283.26-269.48-355.93
Net Income
-149.27-244.17-266.76-283.26-269.48-355.93
Net Income to Common
-149.27-244.17-266.76-283.26-269.48-355.93
Net Income Growth
------
Shares Outstanding (Basic)
289253231195188166
Shares Outstanding (Diluted)
289253231195188166
Shares Change
18.80%9.68%18.68%3.29%13.16%1178.88%
EPS (Basic)
-0.52-0.96-1.16-1.46-1.43-2.14
EPS (Diluted)
-0.52-0.96-1.16-1.46-1.43-2.14
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-145.14-144.77-256.58-273.61-310.93-280.92
Free Cash Flow Per Share
-0.50-0.57-1.11-1.41-1.65-1.69
EBITDA
-131.33-178.21-255.97-309.36-255.8-314
D&A For EBITDA
10.6512.7515.517.5415.6311.07
EBIT
-141.98-190.96-271.47-326.9-271.43-325.07
SEC Filings: 10-K · 10-Q